Sandra Nagel

Sandra Nagel is a clinical research professional with extensive experience in pharmacology and emergency medicine. From May 2008 to April 2010, Sandra served as a Clinical Research Physician at Roche, focusing on recruitment activities and medical monitoring. Additionally, Sandra held the role of Principal Investigator in a Phase 1 Clinical Pharmacology Unit at Roche, overseeing study conduct and quality team involvement. Prior to this, Sandra worked as a Medecin urgentiste at Hôpitaux Universitaires de Strasbourg from January 2003 to March 2013, primarily in the emergency room and intensive care unit. From April 2013 to January 2018, Sandra contributed as a Clinical Pharmacology Scientist at Roche pRED, managing Phase 1 study operations and data analysis. Sandra holds a Diplome d'etat in Medicine from Faculte de Medecine de Strasbourg, completed between 1989 and 2003.